Cargando…

Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis

The Mycobacterium tuberculosis genome codes for 20 different cytochromes. These cytochromes are involved in the breakdown of recalcitrant pollutants and the synthesis of polyketide antibiotics and other complex macromolecules. It has been demonstrated that CYP121 is essential for viability of the ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundaramurthi, Jagadish Chandrabose, Kumar, Swetha, Silambuchelvi, Kannayan, Hanna, Luke Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2011
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218315/ https://www.ncbi.nlm.nih.gov/pubmed/22125383

Ejemplares similares

Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB
por: Brindha, Sridharan, et al.
Publicado: (2016)

HLA-A*0201-specific epitopes of Indian HIV-1C as candidates for vaccine design
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2012)

Molecular docking analysis of aplysin analogs targeting survivin protein
por: Shakeel, Eram, et al.
Publicado: (2017)

Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis
por: Santhi, Natchimuthu, et al.
Publicado: (2011)

Insilico analysis and molecular docking of resuscitation promoting factor B (RpfB) protein of Mycobacterium tuberculosis
por: Mylliemngap, Baphilinia Jones, et al.
Publicado: (2012)

Insights from the docking and molecular dynamics simulation of the Phosphopantetheinyl transferase (PptT) structural model from Mycobacterium tuberculosis
por: Rohini, Karunakaran, et al.
Publicado: (2013)

Implication from the predicted docked interaction of sigma H and exploration of its interaction with RNA polymerase in Mycobacterium tuberculosis
por: Gupta, Aayatti Mallick, et al.
Publicado: (2015)

Identification of inhibitors against α-Isopropylmalate Synthase of Mycobacterium tuberculosis using docking-MM/PBSA hybrid approach
por: Pandey, Preeti, et al.
Publicado: (2017)

Docking studies of piperine - iron conjugate with human CYP450 3A4
por: Alugolu, Veerabrahmam, et al.
Publicado: (2013)

Structure based virtual screening to identify inhibitors against MurE Enzyme of Mycobacterium tuberculosis using AutoDock Vina
por: Singh, Shilpi, et al.
Publicado: (2014)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
por: Kavanagh, Madeline E., et al.
Publicado: (2016)

Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of Mycobacterium tuberculosis
por: Bajrai, Leena Hussein, et al.
Publicado: (2022)

DNA polymerase III α subunit from Mycobacterium tuberculosis H37Rv: Homology modeling and molecular docking of its inhibitor
por: Chhabra, Gagan, et al.
Publicado: (2011)

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)

Deletion of cyp125 Confers Increased Sensitivity to Azoles in Mycobacterium tuberculosis
por: Carroll, Paul, et al.
Publicado: (2015)

Homology modeling, active site prediction, and targeting the anti hypertension activity through molecular docking on endothelin – B receptor domain
por: Rayalu, Daddam Jayasimha, et al.
Publicado: (2012)

Docking of phosphonate and trehalose analog inhibitors into M. tuberculosis mycolyltransferase Ag85C: Comparison of the two scoring fitness functions GoldScore and ChemScore, in the GOLD software
por: Annamala, Manoj Kumar, et al.
Publicado: (2007)

A Genomic Signature for Genotyping Mycobacterium tuberculosis
por: Tarazona, David, et al.
Publicado: (2017)

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Comparative modeling and molecular docking of orphan human CYP4V2 protein with fatty acid substrates: Insights into substrate specificity
por: Kumar, Suresh
Publicado: (2011)

Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis
por: Kumar, Amit, et al.
Publicado: (2021)

Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis
por: Quiliano, Miguel, et al.
Publicado: (2011)

Molecular modeling, docking and ADMET studies towards development of novel Disopyramide analogs for potential inhibition of human voltage gated sodium channel proteins
por: Meraj, Khunza, et al.
Publicado: (2012)

Resistome analysis of Mycobacterium tuberculosis: Identification of aminoglycoside 2'-Nacetyltransferase (AAC) as co-target for drug desigining
por: Joshi, Rakesh S, et al.
Publicado: (2013)

A rapid identification technique for drug-resistant Mycobacterium tuberculosis isolates using mismatch specific cleavage enzyme
por: Jaramillo, Luis, et al.
Publicado: (2018)

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors
por: Kishk, Safaa M., et al.
Publicado: (2019)

(19)F-NMR reveals substrate specificity of CYP121A1 in Mycobacterium tuberculosis
por: Campomizzi, Christopher S., et al.
Publicado: (2021)

Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
por: Unissa, Ameeruddin Nusrath, et al.
Publicado: (2011)

Insight from the structural molecular model of cytidylate kinase from Mycobacterium tuberculosis
por: Verma, Nitin Kumar, et al.
Publicado: (2013)

Identification of potential leads against 4-hydroxytetrahydrodipicolinate synthase from Mycobacterium tuberculosis
por: Rehman, Ajijur, et al.
Publicado: (2016)

DDTRP: Database of Drug Targets for Resistant Pathogens
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Dataset of potential targets for Mycobacterium tuberculosis H37Rv through comparative genome analysis
por: Asif, Siddiqui M, et al.
Publicado: (2009)

Computational finding of potential inhibitor for Cytochrome P450 Mono-oxygenases Enzyme of Mycobacterium tuberculosis
por: Sharma, Ashwani, et al.
Publicado: (2012)

Insights from the protein-protein interaction network analysis of Mycobacterium tuberculosis toxin-antitoxin systems
por: Thakur, Zoozeal, et al.
Publicado: (2017)

Insights from the predicted epitope similarity between Mycobacterium tuberculosis virulent factors and its human homologs
por: Gutlapalli, Venkata Ravi, et al.
Publicado: (2015)

On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds
por: Casadevall, Arturo, et al.
Publicado: (2019)

Designing novel inhibitors against Mycobacterium tuberculosis FadA5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds
por: Jaiswal, Atul Kumar, et al.
Publicado: (2018)

In silico identification and characterization of a hypothetical protein of Mycobacterium tuberculosis EAI5 as a potential virulent factor
por: Gupta, Debdoot, et al.
Publicado: (2016)

Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors
por: Kavanagh, Madeline E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1osodh95v9ejbvgs4llv239vbb